Rabbit Recombinant Monoclonal RAB8A phospho S111 antibody. Suitable for WB and reacts with Mouse, Human samples. Cited in 1 publication.
IgG
Rabbit
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Liquid
Monoclonal
WB | |
---|---|
Human | Tested |
Mouse | Tested |
Species | Dilution info | Notes |
---|---|---|
Species Mouse | Dilution info 1/1000 | Notes - |
Species Human | Dilution info 1/1000 | Notes - |
Select an associated product type
The small GTPases Rab are key regulators of intracellular membrane trafficking, from the formation of transport vesicles to their fusion with membranes. Rabs cycle between an inactive GDP-bound form and an active GTP-bound form that is able to recruit to membranes different sets of downstream effectors directly responsible for vesicle formation, movement, tethering and fusion. That Rab is involved in polarized vesicular trafficking and neurotransmitter release. Together with RAB11A, RAB3IP, the exocyst complex, PARD3, PRKCI, ANXA2, CDC42 and DNMBP promotes transcytosis of PODXL to the apical membrane initiation sites (AMIS), apical surface formation and lumenogenesis (PubMed:20890297). Together with MYO5B and RAB11A participates in epithelial cell polarization (PubMed:21282656). May be involved in ciliogenesis (PubMed:21844891, PubMed:30398148). Together with MICALL2, may also regulate adherens junction assembly (By similarity). May play a role in insulin-induced transport to the plasma membrane of the glucose transporter GLUT4 and therefore play a role in glucose homeostasis (By similarity). Involved in autophagy (PubMed:27103069).
Ras-related protein Rab-8A, Oncogene c-mel, RAB8A, RAB8, MEL
Rabbit Recombinant Monoclonal RAB8A phospho S111 antibody. Suitable for WB and reacts with Mouse, Human samples. Cited in 1 publication.
Ras-related protein Rab-8A, Oncogene c-mel, RAB8A, RAB8, MEL
IgG
Rabbit
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Liquid
Monoclonal
MJF-R27-30
Affinity purification Protein A
Blue Ice
1-2 weeks
+4°C
-20°C
Upon delivery aliquot
Avoid freeze / thaw cycle
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
This antibody was developed with support from The Michael J. Fox Foundation.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Blocking and diluting buffer and concentration: 5% NFDM/TBST.
CCCP (carbonyl cyanide m-chlorophenyl hydrazone) inhibits oxidative phosphorylation.
The lysates were kindly provided by Pawan Singh Ph.D, University of Dundee.
Exposure time: 3min
All lanes: Western blot - Anti-RAB8A (phospho S111) antibody [MJF-R27-30] (ab267492) at 1/1000 dilution
Lane 1: Wild-type HeLa (human cervix adenocarcinoma epithelial cell) treated with DMSO at 20 µg
Lane 2: Wild-type HeLa (human cervix adenocarcinoma epithelial cell) treated with 10 uM CCCP at 20 µg
Lane 3: RAB8A knockout HeLa (human cervix adenocarcinoma epithelial cell) treated with DMSO at 20 µg
Lane 4: RAB8A knockout HeLa (human cervix adenocarcinoma epithelial cell) treated with 10 uM CCCP at 20 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/100000 dilution
Predicted band size: 24 kDa
Observed band size: 23 kDa
Blocking and diluting buffer and concentration: 5% NFDM/TBST.
CCCP (carbonyl cyanide m-chlorophenyl hydrazone) inhibits oxidative phosphorylation.
The lysates were kindly provided by Pawan Singh Ph.D, University of Dundee.
Exposure time: 3min
This data was developed using the same antibody clone in a different buffer formulation containing PBS, glycerol, BSA and sodium azide (Recombinant Human STAT1 protein (Tagged) ab276492).
10 ug/well NIH/3T3 (Mouse embryonic fibroblast cell line) whole cell lysate.
Anti-RAB8A (phospho S111) antibody (ab267492) and Anti-RAB8A antibody (Anti-RAB8A antibody [EPR14873] ab188574) at 1/1000 dilution.
Gel: 4-20% TGX gel
Blocking buffer: 5% BSA blocking buffer
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com